TY - JOUR T1 - Participatory syndromic surveillance as a tool for tracking COVID-19 in Bangladesh JF - medRxiv DO - 10.1101/2020.08.28.20183905 SP - 2020.08.28.20183905 AU - Ayesha S. Mahmud AU - Shayan Chowdhury AU - Kawsar Hossain Sojib AU - Anir Chowdhury AU - Md. Tanvir Quader AU - Sangita Paul AU - Md. Sheikh Saidy AU - Ramiz Uddin AU - Kenth Engø-Monsen AU - Caroline Buckee Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/09/01/2020.08.28.20183905.1.abstract N2 - Limitations in laboratory diagnostic capacity and reporting delays have hampered efforts to mitigate and control the ongoing coronavirus disease 2019 (COVID-19) pandemic globally. To augment traditional lab and hospital-based surveillance, Bangladesh established a participatory surveillance system for the public to self-report symptoms consistent with COVID-19 through multiple channels. Here, we report on the use of this system, which received over 3 million responses within two months, for tracking the COVID-19 outbreak in Bangladesh. Although we observe considerable noise in the data and initial volatility in the use of the different reporting mechanisms, the self-reported syndromic data exhibits a strong association with lab-confirmed cases at a local scale. Moreover, the syndromic data also suggests an earlier spread of the outbreak across Bangladesh than is evident from the confirmed case counts, consistent with predicted spread of the outbreak based on population mobility data. Our results highlight the usefulness of participatory syndromic surveillance for mapping disease burden generally, and particularly during the initial phases of an emerging outbreak.Competing Interest StatementThe authors have declared no competing interest.Funding StatementResearch effort by COB was enabled by a Maximizing Investigator's Research Award from the National Institute of General Medical Sciences (R35GM124715).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:CPHS/OPHS at UC Berkeley (Protocol ID: 2020-07-13485)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData was made available through partnership with a2i in Bangladesh. ER -